company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2026000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2026000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1278000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1278000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,748000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1479000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2404000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2832000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6715000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5967000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-82000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-720000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6687000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6687000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6687000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-6123000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-564000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,786026.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,786026.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3539000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3539000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2341000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2341000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1198000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1845000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2928000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1696000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6469000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5271000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,673000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-424000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1097000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9314886.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9314886.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9400000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:50:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4752000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4752000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1948000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1948000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2804000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2267000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2899000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1119000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6285000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3481000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,679000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-90000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-769000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9314886.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9314886.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9200000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:05:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5159000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5159000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2060000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2060000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3099000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2579000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3180000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5403000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11820000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8721000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,694000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2342000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1648000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7073000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7073000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7073000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6123000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13196000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9316034.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.42
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9316034.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.42
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.42
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11059000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11059000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1764000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1764000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9295000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2362000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4423000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1690000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8475000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,820000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,673000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-677000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14077329.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15700127.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18821000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18821000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2594000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2594000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16227000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2787000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6331000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1921000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11039000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5188000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,272000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-266000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4922000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4547000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4547000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4547000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24972357.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26058102.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 10:32:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29211000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29211000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3096000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3096000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26115000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4274000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7969000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1737000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13980000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12135000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12119000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,532000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11587000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11587000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11587000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32107026.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34183707.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32200000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:06:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40198000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40198000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5211000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5211000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34987000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6949000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,10471000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3151000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20571000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14416000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-32000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14393000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9707000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51839536.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57469234.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41636000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41636000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4773000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4773000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36863000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8568000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,11618000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4008000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24194000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12669000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,19000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12688000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5030000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33566416.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36902578.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55696000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55696000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6555000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6555000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49141000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10689000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14077000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9189000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33955000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15186000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15212000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5747000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68596652.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72673154.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67600000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:11:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58281000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58281000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5390000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5390000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52891000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10790000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15061000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7018000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32869000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20022000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,43000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20065000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8560000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11505000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11505000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11505000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69233526.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73128932.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67700000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:18:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63479000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63479000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5860000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5860000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57619000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14236000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17349000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12921000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44506000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13113000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,65000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13178000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5752000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7426000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7426000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7426000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68759070.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73335132.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-1201800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67692000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67692000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6375000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6375000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61317000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13246000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20916000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10602000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8000000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52764000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8553000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,125000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,125000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8678000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2811000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5867000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5867000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5867000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70916828.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74918318.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-195600000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,80200000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,80200000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8305000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8305000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71895000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15284000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,21986000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17796000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2304000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57370000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14525000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,135000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14660000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5247000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9413000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9413000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9413000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71517442.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75478649.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,313800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,2017-04-07 17:22:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88517000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88517000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7707000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7707000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80810000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12580000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19217000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12322000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,312000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44431000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36379000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,128000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,91000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36470000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11840000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24630000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24630000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24630000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71905183.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75991330.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-1231500000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,2017-04-07 17:24:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,93914000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,93914000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6467000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6467000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87447000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21838000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18549000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16061000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56448000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30999000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,144000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,43000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,187000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31186000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13043000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71592581.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75707651.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71700000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60421000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60421000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55783000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14698000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19035000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53533000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,225000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,274000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,234000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2290000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2290000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2290000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71592089.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74462878.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69221000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69221000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6273000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6273000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62948000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13924000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19691000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22889000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56504000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6444000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,256000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,251000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6695000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,668000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6027000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6027000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6027000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71543809.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74053550.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 18:29:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57773000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57773000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4677000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4677000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53096000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17653000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16662000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16516000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50831000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2265000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,281000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,281000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2546000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-379000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2925000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2925000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2925000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71640536.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74328963.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 06:05:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54860000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54860000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9805000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9805000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45055000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-4177000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13498000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15473000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,23894000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48688000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3633000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,277000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,292000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3341000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,311000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3652000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3652000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3652000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71639856.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74166981.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69000000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35962000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35962000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4639000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4639000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31323000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15042000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12934000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43634000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12311000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,435000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,461000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11850000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5326000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71945743.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71945743.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72500000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42576000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42576000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3921000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3921000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38655000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10643000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13292000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14103000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10933000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48971000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10316000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,478000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9838000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1654000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8184000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8184000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8184000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72169361.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72169361.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74400000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:48:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30670000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30670000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7472000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7472000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23198000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11310000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12825000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19552000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,155254000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,198941000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-175743000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,510000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-83000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,427000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-175316000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9036000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166280000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-166280000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-166280000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72810827.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.28
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72810827.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.28
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-8314000000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 13:45:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31485000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31485000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4611000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4611000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26874000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9492000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7095000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16365000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,14583000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47535000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20661000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,471000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,470000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20191000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25656000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45847000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45847000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45847000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72636780.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72636780.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-5670900000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23911000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23911000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2204000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2204000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21707000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9552000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9051000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12260000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11077000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41940000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20233000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,503000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-469000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20199000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,171000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20370000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20370000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20370000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73745202.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73745202.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23466000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23466000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3596000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3596000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19870000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10875000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9079000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16473000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11148000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47575000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27705000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,484000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,481000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27224000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,126000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73920645.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73920645.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:48:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18346000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18346000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2379000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2379000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15967000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8906000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7358000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14483000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,16039000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46786000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30819000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,483000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,483000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30336000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,158000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30494000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30494000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30494000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74254177.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74254177.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74400000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 13:45:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16357000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16357000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2624000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2624000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13733000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9935000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5884000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14356000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,32524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62699000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48966000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,514000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-196000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,318000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48648000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2355000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46293000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46293000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46293000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74073665.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74073665.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7630000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7630000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4575000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4575000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3055000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10986000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4119000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10523000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,99540000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,125168000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-122113000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,423000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-908000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-485000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-122598000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1246000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-123844000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-123844000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-123844000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74426030.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.66
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74426030.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.66
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74600000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.66
